Genta Dilutes its Ownership
Genta (Nasdaq:GNTA) is a biopharmaceutical company which researches DNA and RNA medicines with the goal of finding new ways to treat cancer and similar diseases. The company recently announced that it will sell an additional 20 million shares on top of the 134 million shares that are currently outstanding. Investors where not happy to hear this and Genta’s share price dropped over 27%.